Aspartic Acid

Aspartic Acid

SCHEMBL693371

N[C@@H](CC(=O)O)C(=O)[O-].N[C@@H](CC(=O)O)C(=O)[O-].N[C@@H](CC(=O)O)C(=O)[O-].[Fe+3]

nearest known ligand 0.39

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

SLC6A2SLC6A3SSTR1SSTR2SSTR3SSTR5

The experimentally established mechanism targets of Aspartic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC22A6 Q4U2R8 1/20 0.39
GABRR1 P24046 2/20 0.39
LMNA P02545 1/20 0.39
TDP1 Q9NUW8 1/20 0.38
GRIK1 P39086 2/20 0.37
GRIK2 Q13002 2/20 0.37
GRM1 Q13255 2/20 0.37
GRM2 Q14416 2/20 0.37
GRM8 O00222 1/20 0.37
GRM6 O15303 1/20 0.37
GRIN2D O15399 1/20 0.37
GRIN3B O60391 1/20 0.37
GSR P00390 1/20 0.37
CYP1A2 P05177 1/20 0.37
GRM5 P41594 1/20 0.37
GRIA1 P42261 1/20 0.37
GRIA2 P42262 1/20 0.37
GRIA3 P42263 1/20 0.37
SLC1A3 P43003 1/20 0.37
SLC1A2 P43004 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Aspartic Acid SCHEMBL11111882 0.97 SLC22A6 (0.38) SLC22A6GABRR1LMNATDP1GRIK1
Aspartic Acid SCHEMBL1987594 0.97 SLC22A6 (0.41) SLC22A6GABRR1LMNATDP1GRIK1
Aspartic Acid SCHEMBL5247248 0.95 SLC22A6 (0.39) SLC22A6GABRR1LMNATDP1GRIK1
Aspartic Acid SCHEMBL14343482 0.95 SLC22A6 (0.39) SLC22A6GABRR1LMNATDP1GRIK1
Aspartic Acid SCHEMBL11903450 0.95 SLC22A6 (0.39) SLC22A6GABRR1LMNATDP1GRIK1
Aspartic Acid SCHEMBL120544 0.95 SLC22A6 (0.39) SLC22A6GABRR1LMNATDP1GRIK1
Aspartic Acid SCHEMBL16431399 0.95 SLC22A6 (0.39) SLC22A6GABRR1LMNATDP1GRIK1
Aspartic Acid SCHEMBL50775 0.95 SLC22A6 (0.39) SLC22A6GABRR1LMNATDP1GRIK1
Aspartic Acid SCHEMBL518279 0.95 SLC22A6 (0.39) SLC22A6GABRR1LMNATDP1GRIK1
Aspartic Acid SCHEMBL162426 0.95 SLC22A6 (0.39) SLC22A6GABRR1LMNATDP1GRIK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 205 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3400260-B2 SCAVENGER COMPOSITIONS FOR SULFUR SPECIES INNOPHOS INC (US) 2025-03-19 EP claimed
CN-118496683-A Scavenger composition for sulfur species 伊诺弗斯公司 2024-08-16 CN claimed
CN-115463124-B Iron supplementing effervescent tablet and preparation method thereof 海而思(郑州)科技有限公司 2024-04-05 CN claimed
CN-115463124-A Iron-supplementing effervescent tablet and preparation method thereof 海而思(郑州)科技有限公司 2022-12-13 CN claimed
CN-113317428-A Calcium, iron and zinc solid preparation and preparation method thereof 海而思(郑州)科技有限公司 2021-08-31 CN claimed
WO-2021137780-A1 PREPARATION OF FILM TABLET COMPOSITION COMPRISING HEME IRON FOR IRON DEFICIENCY İLKO İLAÇ SANAYİ VE TİCARET A.Ş. (TR) 2021-07-08 WO claimed
EP-3216782-B1 IRON AMINO ACID COMPOUNDS, METHOD FOR PREPARING IRON AMINO ACID COMPOUNDS, COMPOSITIONS CONTAINING IRON AMINO ACID COMPOUNDS, AND USES THEREOF NPA NUCLEO DE PESQUISAS APLICADAS LTDA (BR) 2021-06-02 EP claimed
EP-3400260-B1 SCAVENGER COMPOSITIONS FOR SULFUR SPECIES INNOPHOS INC (US) 2021-06-02 EP claimed
US-10995280-B2 Scavenger compositions for sulfur species INNOPHOS, INC. (US) 2021-05-04 US claimed
US-20210122705-A1 IRON AMINO ACID COMPOUNDS, METHOD FOR PREPARING IRON AMINO ACID COMPOUNDS, COMPOSITIONS CONTAINING IRON AMINO ACID COMPOUNDS, AND USES THEREOF NPA NUCLEO DE PESQUISAS APLICADAS LTDA (BR) 2021-04-29 US claimed
EP-2421601-A2 METHOD FOR TRANSDERMAL IONTOPHORETIC DELIVERY OF CHELATED AGENTS Incube Labs, Llc (US) 2012-02-29 EP claimed
WO-2010123584-A2 METHOD FOR TRANSDERMAL IONTOPHORETIC DELIVERY OF CHELATED AGENTS INCUBE LABS, LLC (US) 2010-10-28 WO claimed
US-20090035385-A1 COMPOSITIONS INCLUDING IRON DRUGTECH CORPORATION (US) 2009-02-05 US claimed
EP-1827418-A2 COMPOSITIONS INCLUDING IRON Drugtech Corporation (US) 2007-09-05 EP claimed
EP-1827419-A2 METHODS AND COMPOSITIONS FOR ENHANCING IRON ABSORPTION Drugtech Corporation (US) 2007-09-05 EP claimed
WO-2006068697-A2 COMPOSITIONS INCLUDING IRON DRUGTECH CORPORATION (US) 2006-06-29 WO claimed
WO-2006068729-A2 METHODS AND COMPOSITIONS FOR ENHANCING IRON ABSORPTION DRUGTECH CORPORATION (US) 2006-06-29 WO claimed
US-20060134227-A1 Compositions including iron DRUGTECH CORPORATION 2006-06-22 US claimed
WO-2003086321-A2 MODIFIED RELEASE MINERALS DRUGTECH CORPORATION (US) 2003-10-23 WO claimed
US-20030190355-A1 Modified release minerals DRUGTECH CORPORATION 2003-10-09 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210122705-A1 IRON AMINO ACID COMPOUNDS, METHOD FOR PREPARING IRON AMINO ACID COMPOUNDS, COMPOSITIONS CONTAINING IRON AMINO ACID COMPOUNDS, AND USES THEREOF HAMP, FECH, TFRC SLC22A6 257/4885GABRR1 1964/4885LMNA 4114/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.